Search

Author/Creator Cheng, Huanqing

2. Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer. Issue 10 (23rd September 2019)

Authors:
Zhou, Xiaoyun; Shou, Jiawei; Sheng, Jin; Xu, Chunwei; Ren, Shengxiang; Cai, Xiuyu; Chu, Qian; Wang, Wenxian; Zhen, Qinhong; Zhou, Yuefen; Li, Wenfeng; Pan, Hong; Li, Hongsen; Sun, Tao; Cheng, Huanqing; Wang, Huina; Lou, Feng; Rao, Chuangzhou; Cao, Shanbo; Pan, Hongming
Journal:
Cancer science
Issue:
Volume 110:Issue 10(2019)
Page Start:
3382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma. Issue 11 (12th September 2021)

Authors:
Pan, Hongming; Cheng, Huanqing; Wang, Huina; Ge, Weiting; Yuan, Meiqin; Jiang, Sujing; Wan, Xiangbo; Dong, Ying; Liu, Zhen; Zhao, Rongjie; Fang, Yong; Lou, Feng; Cao, Shanbo; Han, Weidong
Journal:
Cancer science
Issue:
Volume 112:Issue 11(2021)
Page Start:
4758
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer. (28th November 2022)

Authors:
Jiang, Wensheng; Cheng, Huanqing; Yu, Lili; Zhang, Jie; Wang, Yihui; Liang, Yun; Lou, Feng; Wang, Huina; Cao, Shanbo
Journal:
Cancer medicine
Issue:
Volume 12:Number 6(2023)
Page Start:
6649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗